Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D04DOL
|
|||
Former ID |
DNC009745
|
|||
Drug Name |
N1-(biphenyl-4-yl)-N8-hydroxyoctanediamide
|
|||
Synonyms |
CHEMBL512644; N1-(biphenyl-4-yl)-N8-hydroxyoctanediamide; SCHEMBL8226957
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C20H24N2O3
|
|||
Canonical SMILES |
C1=CC=C(C=C1)C2=CC=C(C=C2)NC(=O)CCCCCCC(=O)NO
|
|||
InChI |
1S/C20H24N2O3/c23-19(10-6-1-2-7-11-20(24)22-25)21-18-14-12-17(13-15-18)16-8-4-3-5-9-16/h3-5,8-9,12-15,25H,1-2,6-7,10-11H2,(H,21,23)(H,22,24)
|
|||
InChIKey |
MIYLHRAVWYBTPV-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | Isoxazole moiety in the linker region of HDAC inhibitors adjacent to the Zn-chelating group: effects on HDAC biology and antiproliferative activity. Bioorg Med Chem Lett. 2009 Jun 1;19(11):3023-6. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.